The University Colorado Technology Transfer Office and Snell & Wilmer brought us a wonderful lunch seminar yesterday titled Patenting Early Stage Therapeutics. I took my first stab at capturing the audio and publishing the podcast here at CLSDF. The first few minutes are a bit choppy but the audio improves around the four minute mark.
Sit [...]

• 195http://clsdf.com/2007/07/podcast-patenting-early-stage-therapeutics/Podcast%3A+Patenting+Early+Stage+Therapeutics2007-07-19+16%3A23%3A00admin

AlphaSnifer, developer of highly sensitive biosensors for the detection of trace amounts (~pg/mm^2) of bacteria, viruses, proteins, nucleic acids, antibodies and other biological and chemical agents, in real time, announced they received U.S. Patent #7,233,396, “Polarization based interferometric detector”.
In addition, as Dr. Misha Plam, President and CEO of AlphaSniffer, gears up to raise [...]

• 194http://clsdf.com/2007/07/alphasniffer-detecting-it-all%e2%80%a6/AlphaSniffer%3A+Detecting+It+All%E2%80%A62007-07-16+14%3A40%3A00admin

It appears as though Bill Freytag, Ph.D. former chief executive of Myogen will be assuming the CEO and chair positions with Aspreva Pharmaceuticals (NASDAQ: ASPV) effective immediately. We wish him the best of luck in this next chapter and appreciate all that Dr. Freytag has done for the Colorado life science landscape. Aspreva, based in [...]

• 193http://clsdf.com/2007/07/j-william-freytag-ceo-of-aspreva-pharma/J.+William+Freytag%3A+CEO+of+Aspreva+Pharma2007-07-12+05%3A36%3A00admin

Congratulations to Arlen Meyers, MD, MBA who has been appointed as the Academic Director of the Bard Center Bioentrepreneurship Program.
Program details may be found (here). The inaugural Class I Bard Bio Fellows are off to the races. The Fellows among others will be taking Dr. Meyers Fundamentals of Bioscience Technology Transfer course beginning in August [...]

• 192http://clsdf.com/2007/07/new-bioentrepreneur-director-at-bard/New+Bioentrepreneur+Director+at+Bard2007-07-11+16%3A05%3A00admin

Here is a link to a great piece on the Colorado bio-scape in today’s Denver Business Journal titled Building a Biotech Hub Means Bridging Some Gaps.
Thanks to Greg Avery for the informative work.

• 191View 2 Comments...http://clsdf.com/2007/07/denver-bizjournal-article-biotech-hub/Denver+BizJournal+Article%3A+Biotech+Hub2007-07-10+16%3A20%3A00admin

Since the launch of CLSDF I’ve worked diligently to keep my personal life off of this blog, primarily because who out there really cares what I am up to outside of my bio-life. Well, I can no longer contain myself and must now spill the beans about what I have been up to since Friday [...]

• 190http://clsdf.com/2007/07/now-something-completely-different%e2%80%a6/Now...Something+Completely+Different%E2%80%A62007-07-08+19%3A14%3A00admin

The new Bard Center Bioscience Program (BCBP) is an intensive, year-long program that equips emerging Colorado life scientists with the knowledge, skills, experience and contacts to integrate as a value-add contributor into the region’s biocluster. BCBP provides a pathway for life science graduate, postdoctoral and business students to gain employment in the Colorado bioscience ecosystem [...]

• 189http://clsdf.com/2007/07/class-i-bard-bio-fellows-named/Class+I+Bard+Bio-Fellows+Named%212007-07-05+22%3A04%3A00admin